Publications scientifiques sur le VIH
Cost-Effectiveness of ibalizumab versus routine clinical care in heavily treatment experienced (HTE) people with HIV in the United States (US)
2023
Brandon Cash, Lydia Walder, Cianne Park, Andrew Laws
Abstract 107.8 KB
Tesamorelin reduces visceral adipose tissue and liver fat in INSTI-treated persons with HIV
2023
Taryn McLaughlin, Takara L Stanley , Lindsay T Fourman , Steve Grinspoon
Abstract 170.3 KB
Virologic effectiveness of ibalizumab clinical trial experience compared to real-world clinical care without ibalizumab in the OPERA® Cohort
2023
Laurence Brunet, Michele L. Jonsson Funk, R Brandon Cash, Jennifer S. Fusco, Lydia Walder, Andrew Laws, Michael Wohlfeiler, Michael Sension, Gregory P. Fusco
Abstract 2.3 MB
Achieving virological control in pan-resistant HIV-1 infection: A case series
2022
Diana Canetti, Camilla Muccini, Vincenzo Spagnuolo, Laura Galli, Andrea Poli, Nicola Gianotti, Marcello Feasi, and Antonella Castagna,
Vol 77 Month March, 2022 11
HIV-1 Non-Group M Phenotypic Susceptibility to Ibalizumab
2022
L. Poisson-Arnaud, Quentin le Hingrat, JC Plantier and E Alessandri-Gradt